Nurix Therapeutics Inc. (NRIX)

AI Score

Unlock

11.51

-0.10 (-0.86%)

At close: Apr 24, 2025, 1:25 PM

Nurix Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is December - November.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Feb 28, 2025	Nov 30, 2024	Aug 31, 2024	May 31, 2024	Feb 29, 2024	Nov 30, 2023	Aug 31, 2023	May 31, 2023	Feb 28, 2023	Nov 30, 2022	Aug 31, 2022	May 31, 2022	Feb 28, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021	Nov 30, 2020	Aug 31, 2020	May 31, 2020	Feb 29, 2020	Nov 30, 2019	Feb 28, 2019
Cash & Equivalents	75.92M	110M	99.04M	116.79M	49.81M	54.63M	42.3M	58.96M	33.57M	64.47M	47.56M	41.53M	78.78M	80.51M	147.44M	188.21M	126.38M	119.36M	265.53M	159.33M	56.41M	34.82M	-39.04M
Short-Term Investments	473.76M	499.59M	349.01M	326.35M	194.18M	233.28M	216.55M	222.22M	243.57M	244.67M	296.92M	255.75M	183.2M	215.21M	196.46M	197.81M	176.69M	161.79M	88.72M	14.17M	14.94M	2.9M	78.08M
Long-Term Investments	n/a	n/a	n/a	10.28M	11.19M	8.32M	9.88M	27.46M	48.45M	63.88M	69.13M	51.54M	123.69M	137.19M	121.48M	110.44M	77.19M	90.89M	40.9M	9.11M	7.58M	506K	n/a
Other Long-Term Assets	6.53M	4.06M	13.4M	3.14M	3.34M	3.82M	4.76M	4.71M	4.74M	4.92M	4.99M	5.06M	4.16M	-207K	3.58M	2.92M	1.74M	347K	355K	1.57M	570K	317K	-39.04M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	2M	n/a	n/a	n/a	n/a	n/a	8.2M	6.2M	5.2M	5.68M	3.98M	11.35M	3.86M	19.59M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	1.00	-1M	-1.2M	-1.1M	-1.1M	-700K	1.00	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	14.02M	9.8M	7.99M	7.08M	6.98M	7.59M	7.1M	8.84M	11.18M	9.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.31M	n/a	n/a
Total Current Assets	563.7M	619.39M	456.04M	450.22M	250.97M	295.5M	267.95M	290.01M	288.33M	318.45M	354.87M	306.79M	280.48M	311.12M	358.44M	396.28M	310.77M	298.43M	364.09M	196.8M	76.66M	39.35M	39.04M
Property-Plant & Equipment	44.81M	45.9M	44.15M	47.39M	47.17M	47.95M	25.61M	28.44M	28.63M	29.51M	30.35M	30.93M	29.39M	25.34M	9.57M	8.35M	6.96M	6.67M	6.53M	5.79M	3.98M	3.87M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	-3.3M	n/a	n/a	n/a	-3.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	51.34M	49.96M	57.56M	60.81M	61.7M	69.04M	40.25M	60.61M	81.83M	98.31M	104.47M	87.52M	157.24M	165.65M	134.63M	121.7M	85.89M	97.91M	47.78M	16.47M	12.13M	4.69M	-39.04M
Total Assets	615.04M	669.34M	513.6M	511.03M	312.67M	364.54M	308.19M	350.62M	370.15M	416.76M	459.34M	394.31M	437.72M	476.77M	493.07M	517.98M	396.66M	396.34M	411.87M	213.28M	88.79M	44.05M	n/a
Account Payables	8.4M	11.48M	3.92M	2.81M	5.92M	6.4M	2.19M	4.53M	5.63M	5.06M	6.05M	6.14M	6.01M	6.65M	3.86M	5.41M	4.39M	3.41M	3.61M	4.9M	2.13M	1.6M	n/a
Deferred Revenue	30.59M	38.36M	48M	46.77M	46.08M	48.1M	32.04M	44.06M	38.3M	37.63M	36.34M	41.32M	43.19M	41.21M	35.25M	33.76M	32.75M	32.8M	30.3M	25.37M	n/a	9.61M	n/a
Short-Term Debt	6.64M	n/a	6.55M	7.93M	7.31M	7.49M	5.36M	5.58M	5.56M	5.53M	5.5M	5.47M	5.43M	3.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	44.36M	18.91M	8.66M	5.45M	10.19M	8.56M	7.01M	4.73M	3.03M	9.14M	6.47M	6.38M	1.93M	5.67M	5.53M	2.69M	3.24M	2.6M	3.34M	1.64M	27.91M	1.18M	n/a
Total Current Liabilities	89.99M	95.85M	86.3M	80.78M	87.62M	86.96M	61.49M	72.26M	64.88M	70.66M	67.5M	72.67M	66.05M	66.26M	50.68M	46.84M	47.97M	44.54M	41.01M	34.44M	30.03M	16.14M	n/a
Long-Term Debt	19.98M	n/a	n/a	20.89M	21.85M	23.13M	2.64M	3.76M	5.11M	6.43M	7.75M	9.04M	10.33M	9.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	24.15M	n/a	n/a	-20.89M	-21.85M	-23.13M	-2.64M	-3.76M	-5.11M	-6.43M	-7.75M	-9.04M	-10.33M	-9.19M	796K	837K	832K	850K	868K	871K	n/a	49.93M	n/a
Total Long-Term Liabilities	44.14M	46.5M	50.45M	59.56M	56.3M	77.09M	12.88M	18.44M	31.22M	42.41M	49.29M	54.91M	65.75M	68.21M	67.18M	72.96M	78.56M	61.53M	63.24M	72.26M	n/a	85.63M	n/a
Total Liabilities	134.13M	142.35M	136.74M	140.34M	143.93M	164.05M	74.38M	90.7M	96.1M	113.06M	116.79M	127.57M	131.8M	134.47M	117.86M	119.8M	126.53M	106.07M	104.25M	106.69M	30.03M	101.76M	n/a
Total Debt	26.62M	28.3M	27.14M	28.82M	29.16M	30.61M	8M	9.34M	10.66M	11.96M	13.24M	14.51M	15.76M	13.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	76K	76K	67K	64K	49K	49K	49K	48K	47K	47K	47K	45K	45K	45K	45K	44K	39K	39K	39K	26K	11K	4K	n/a
Retained Earnings	-795.12M	-738.77M	-680.22M	-631.26M	-586.72M	-545.2M	-503.24M	-466.26M	-441.99M	-401.25M	-354.54M	-308.83M	-263.43M	-220.89M	-183.19M	-154.35M	-127.97M	-103.7M	-83.78M	-65.27M	-72.85M	-60.46M	n/a
Comprehensive Income	226K	150K	344K	-135K	-350K	-655K	-1.23M	-1.9M	-3.25M	-4.32M	-3.74M	-3.08M	-2.07M	-608K	-59K	30K	49K	87K	138K	139K	57K	-2K	-36.85M
Shareholders Equity	480.92M	526.99M	376.86M	370.69M	168.75M	200.49M	233.82M	259.92M	274.05M	303.7M	342.55M	266.74M	305.92M	342.3M	375.22M	398.18M	270.13M	290.27M	307.62M	106.58M	-21.61M	-57.71M	11.35M
Total Investments	473.76M	499.59M	349.01M	336.63M	205.37M	241.6M	216.55M	222.22M	292.02M	308.55M	366.05M	307.28M	306.88M	352.4M	317.94M	308.25M	253.88M	252.68M	129.61M	23.28M	22.52M	3.41M	78.08M